DCHCF yields 23.30% · PFE yields 6.13%● Live data
📍 DCHCF pulled ahead of the other in Year 1
Combined, DCHCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DCHCF + PFE for your $10,000?
Dainichiseika Color & Chemicals Mfg. Co., Ltd. manufactures and sells a range of pigments and colorants. It provides inorganic, organic, and processed pigments for applications, including paints, printing inks, and information display and recording materials; colorants for industries comprising mass colorants for synthetic fibers, pigmented printing agents, and colorants for paper and construction materials; and functional materials for polyvinyl chloride, high-performance fluororesin, and various thermoplastic and thermosetting resins, as well as for electronics and information materials, automotive, and interior construction materials fields. The company also offers UV and EB curable coating materials, decorative, and functional coating materials; and polyurethane and colorants used in synthetic leather and molded products, coating agents, and adhesives, as well as imide-based resins. In addition, it provides Chitosan, a polymer product made from crab shells, as well as its derivatives; functional inks and offset printing inks used in paper media, such as flyers, books, and packaging materials; gravure inks; and coating agents and flexographic printing inks. The company was founded in 1931 and is headquartered in Tokyo, Japan.
Full DCHCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.